Form 4: Ginkgo Bioworks Director Harry Sloan Acquires Shares Through Distribution

Director Harry Sloan acquired 235,780 shares of Ginkgo Bioworks Class A Common Stock through a distribution from Eagle Equity Partners III LLC.

Summary

• Harry Sloan, a director at Ginkgo Bioworks Holdings, Inc., acquired 235,780 shares of Class A Common Stock on December 11, 2024.
• The shares were received as a distribution from Eagle Equity Partners III LLC to its members.
• Following the transaction, Mr. Sloan beneficially owns 260,597 shares of Ginkgo Bioworks.
• The reported share amount reflects a 1-for-40 reverse stock split that Ginkgo Bioworks implemented on August 20, 2024.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction by a director, which is neither particularly positive nor negative. It indicates confidence from the director but is not a major event.

Positives

• A director increasing their stake in the company can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to changes in beneficial ownership by a company director, and is not indicative of any broader industry trends.

Stakeholder Impact

• The increase in a director's shareholding may be viewed positively by shareholders.

Key Dates

Keywords

Ginkgo Bioworks, Harry Sloan, Director, Share Acquisition, Class A Common Stock, Eagle Equity Partners III LLC, Beneficial Ownership, Reverse Stock Split